Suven Life Sciences Limited · NSE:SUVEN
Suven Life Sciences — Investor Presentation (2006)
9 slides from Suven Life Sciences's investor presentation, Nov 13, 2006
Slide 1: SUVEN Life Sciences
SUVEN Life Sciences Partnering Drug Discovery & Development ……and beyond!
Slide 2: Suven's Business Model
Suven’s Business Model Drug Discovery Chem Lead lib/ identifica Lead ANDA Pre Clinical Process Custom comb tion/ Optimiza- based Clinical Trials Research Synthesis chem characte tion generics hits r-sation Drug Discovery & Development C-R-A-M-S Support Services (DDDSS) Collaborative partner .. Seaml
Slide 3: Origins
Origins • Started in 1989 • Profitable for the last decade • Strong asset base and financial fundamentals • Pioneering efforts in C-R-A-M-S in 1994 • Relationships with many Global Life Science majors • IPO in 1995 - Listed on NSE and BSE • Market capitalization - $ 50 million • Pioneering initiativ
Slide 4: Strategic Business Segments
Strategic Business Segments •Contract Research and Manufacturing Services (C-R-A-M-S) •Drug Discovery and Development Support Services (DDDSS) •Clinical Research & Data management services Full spectrum services in Drug Discovery, Development and Manufacturing
Slide 5: Facilities
Facilities § R&D and Pilot facility, Jeedimetla, Hyderabad § Plant for manufacture of intermediates, Suryapet, Hyderabad § cGMP, FDA compliant plant, Pashamylaram, Hyderabad § Bio-pharmaceutical facility, Banjara Hills, Hyderabad § Clinical Research and Data Management facility, Banjara Hills, Hyder
Slide 6: C-R-A-M-S
C-R-A-M-S • NCEs is a thrust area • Customers include 18 Global Life Science majors • 300+ C-R-A-M-S projects completed till date and 43 are currently being executed. • Profile of projects - Process Research - Customs synthesis - New Chemical Entities based intermediates and APIs More than 65% of re
Slide 7: DDDSS
DDDSS • 2005 initiative- Drug Discovery and Development Support Services (DDDSS) • India is now a part of the Global IP regime • Leverage the India based delivery model • Evolve into a Global CRO, with capability for: – Early and late phase drug development services – Clinical trials management serv
Slide 8: Clinical Research
Clinical Research • Regulatory & Quality Assurance • Project Management • Site Management • Data Management & Biostatistics • Medical Monitoring • Medical Writing • Safety management/Pharmacovigilance • Study supply logistics management • GCP Audit All sponsors from USA
Slide 9: Vision
Vision Emerge as a leading player by providing full spectrum services in drug discovery, development, manufacturing and support services under collaboration with leading global life science players CRAMS DDDSS CRP Contract Research And Manufacturing Services + Drug Discovery Development Support Serv